It is a very cold February night in Berlin. As the snow falls and attendees of the Berlin Film Festival bundle up, Timothée ...

Top 15 Magical Bollywood Love Quotes That Capture ... Earlier this week, the actress told People magazine that a famous actress ended their friendship after she bombed a speech meant to honor ...

Karla Sofia Gascon, a transgender actress and Oscar nominee, has apologized for old social media posts that denigrated Islam and George Floyd, sparking controversy just days after her historic ...

44,097 people played the daily Crossword recently. Can you solve it faster than others?44,097 people played the daily Crossword recently. Can you solve it faster than others? Nvidia Stock Is Doing ...

These 2 Dividend Stocks Offer Yields Above 6%. Want Decades of Passive Income? 2 Top Dividend Stocks to Buy in 2025 and Hold Forever.

Skyrizi and Rinvoq are expected to generate nearly $24 billion in combined sales in 2025, reflecting a $6 billion increase year-over-year. AbbVie raised its 2027 combined sales guidance for these ...

The loss of Hu­mi­ra ex­clu­siv­i­ty was long ex­pect­ed to be a blow to Ab­b­Vie’s im­munol­o­gy dom­i­nance, but the Skyrizi-Rin­voq tan­dem keeps out­pac­ing ex­pec­ta ...

Truly can't imagining having drama with Reese Witherspoon, but apparently she and an unnamed A-list actress are no longer on speaking terms. Why, you ask? Because Reese accidentally roasted her ...

Sales of its immune-disease therapy Humira were down 49% globally at $1.68 billion, and declined even more steeply in the U.S. The drug was previously AbbVie's top seller but now faces competition ...

AbbVie Q4 adjusted EPS of $2.16 beat estimates, with strong sales of Skyrizi (+57.9%) and Rinvoq (+47.1%) boosting revenue growth. AbbVie raises 2027 revenue forecast for Skyrizi and Rinvoq to $31 ...

Humira net revenues decreased 48.7% on an operational basis to $1.682 billion, Skyrizi net revenues rose 57.9% to $3.778 billion, and Rinvoq revenues gained 47.1% to $1.834 billion. “We are ...